Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alvan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Pharmacokinetics|January 1, 1980
Absorption of ocular timololG Alvan, B Calissendorff, P Seideman, et al.
Journal of Clinical Pharmacology|May 1, 1976
Failure of vitamin C to affect the pharmacokinetic profile of antipyrine in manJ T Wilson, C J Boxtel, G Alvan, et al.
The Annals of Pharmacotherapy|December 1, 1993
Potential savings of consulting a drug information centerH Lyrvall, C Nordin, E Jonsson, et al.
Lancet (London, England)|May 16, 1981
Hydroxylation of debrisoquine in patients with lacticacidosis after phenforminB E Wiholm, G Alvan, L Bertilsson, et al.
Clinical Pharmacokinetics|July 1, 1988
Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosisA Hedman, Y Adan-Abdi, G Alvan, et al.
Acta Ophthalmologica|February 1, 1982
Additive intraocular pressure reducing effect of topical timolol during systemic beta-blockadeN Marén, G Alvan, B M Calissendorff, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Moving toward genetic profiling in patient care: the scope and rationale of pharmacogenetic/ecogenetic investigationG Alvan, L Bertilsson, M L Dahl, et al.
British Journal of Clinical Pharmacology|December 1, 1983
Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malariaO Walker, A H Dawodu, A A Adeyokunnu, et al.
British Journal of Clinical Pharmacology|December 1, 1996
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humansY Böttiger, P Dostert, M S Benedetti, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Pharmacokinetics|January 1, 1980
Absorption of ocular timololG Alvan, B Calissendorff, P Seideman, et al.
Journal of Clinical Pharmacology|May 1, 1976
Failure of vitamin C to affect the pharmacokinetic profile of antipyrine in manJ T Wilson, C J Boxtel, G Alvan, et al.
The Annals of Pharmacotherapy|December 1, 1993
Potential savings of consulting a drug information centerH Lyrvall, C Nordin, E Jonsson, et al.
Lancet (London, England)|May 16, 1981
Hydroxylation of debrisoquine in patients with lacticacidosis after phenforminB E Wiholm, G Alvan, L Bertilsson, et al.
Clinical Pharmacokinetics|July 1, 1988
Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosisA Hedman, Y Adan-Abdi, G Alvan, et al.
Acta Ophthalmologica|February 1, 1982
Additive intraocular pressure reducing effect of topical timolol during systemic beta-blockadeN Marén, G Alvan, B M Calissendorff, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Moving toward genetic profiling in patient care: the scope and rationale of pharmacogenetic/ecogenetic investigationG Alvan, L Bertilsson, M L Dahl, et al.
British Journal of Clinical Pharmacology|December 1, 1983
Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malariaO Walker, A H Dawodu, A A Adeyokunnu, et al.
British Journal of Clinical Pharmacology|December 1, 1996
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humansY Böttiger, P Dostert, M S Benedetti, et al.
Pageof 2